Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 28 | 2024 | 659 | 4.830 |
Why?
|
| Genetic Vectors | 24 | 2024 | 820 | 4.000 |
Why?
|
| Genetic Therapy | 15 | 2024 | 744 | 1.820 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 5 | 2017 | 144 | 1.320 |
Why?
|
| Transduction, Genetic | 7 | 2024 | 233 | 1.300 |
Why?
|
| Osteoblasts | 6 | 2019 | 205 | 1.150 |
Why?
|
| Capsid | 3 | 2024 | 89 | 1.080 |
Why?
|
| Transgenes | 6 | 2024 | 176 | 1.000 |
Why?
|
| Retina | 1 | 2024 | 119 | 0.880 |
Why?
|
| Nanopores | 1 | 2022 | 10 | 0.830 |
Why?
|
| Liver | 2 | 2025 | 788 | 0.820 |
Why?
|
| Cell Differentiation | 4 | 2017 | 1297 | 0.820 |
Why?
|
| Gene Expression | 4 | 2019 | 807 | 0.800 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 351 | 0.760 |
Why?
|
| Gene Transfer Techniques | 8 | 2021 | 307 | 0.680 |
Why?
|
| Osteogenesis | 3 | 2017 | 150 | 0.650 |
Why?
|
| Animals | 32 | 2025 | 19718 | 0.640 |
Why?
|
| Genome, Viral | 5 | 2024 | 122 | 0.630 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 73 | 0.620 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 101 | 0.610 |
Why?
|
| Promoter Regions, Genetic | 7 | 2024 | 661 | 0.610 |
Why?
|
| Genome | 2 | 2017 | 253 | 0.590 |
Why?
|
| CCCTC-Binding Factor | 1 | 2017 | 40 | 0.580 |
Why?
|
| Deoxyribonucleases | 1 | 2017 | 30 | 0.580 |
Why?
|
| Mice | 22 | 2024 | 10303 | 0.510 |
Why?
|
| Genes, Reporter | 4 | 2019 | 243 | 0.480 |
Why?
|
| Eukaryota | 1 | 2014 | 29 | 0.450 |
Why?
|
| Cell Line | 8 | 2019 | 2015 | 0.410 |
Why?
|
| Organ Specificity | 2 | 2025 | 180 | 0.390 |
Why?
|
| beta-Galactosidase | 1 | 2012 | 81 | 0.380 |
Why?
|
| Genomics | 1 | 2014 | 314 | 0.380 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1540 | 0.370 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 86 | 0.370 |
Why?
|
| MicroRNAs | 3 | 2021 | 621 | 0.330 |
Why?
|
| Genetic Engineering | 3 | 2019 | 112 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 3204 | 0.320 |
Why?
|
| Humans | 27 | 2025 | 59799 | 0.320 |
Why?
|
| Gene Editing | 3 | 2021 | 301 | 0.280 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 189 | 0.280 |
Why?
|
| Gene Silencing | 2 | 2019 | 379 | 0.270 |
Why?
|
| Codon | 1 | 2025 | 49 | 0.240 |
Why?
|
| Plasmids | 2 | 2023 | 282 | 0.230 |
Why?
|
| Carcinogenesis | 2 | 2023 | 118 | 0.230 |
Why?
|
| HEK293 Cells | 3 | 2022 | 578 | 0.230 |
Why?
|
| Recombinational DNA Repair | 2 | 2021 | 20 | 0.230 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 1225 | 0.230 |
Why?
|
| Brain | 2 | 2025 | 1492 | 0.220 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2024 | 21 | 0.220 |
Why?
|
| Hepatocytes | 1 | 2025 | 194 | 0.220 |
Why?
|
| Central Nervous System | 3 | 2020 | 192 | 0.210 |
Why?
|
| Terminal Repeat Sequences | 1 | 2022 | 14 | 0.210 |
Why?
|
| Protein Biosynthesis | 1 | 2025 | 294 | 0.210 |
Why?
|
| Recombinant Proteins | 1 | 2025 | 695 | 0.210 |
Why?
|
| Capsid Proteins | 2 | 2020 | 93 | 0.200 |
Why?
|
| Gene Order | 2 | 2019 | 29 | 0.200 |
Why?
|
| Baculoviridae | 1 | 2022 | 26 | 0.200 |
Why?
|
| Insecta | 1 | 2022 | 38 | 0.200 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 11 | 0.190 |
Why?
|
| Tyrosinemias | 1 | 2021 | 19 | 0.190 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 34 | 0.190 |
Why?
|
| Microglia | 1 | 2024 | 228 | 0.190 |
Why?
|
| Retinal Vasculitis | 1 | 2021 | 8 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 259 | 0.180 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 29 | 0.180 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 848 | 0.180 |
Why?
|
| Lentivirus | 1 | 2021 | 62 | 0.180 |
Why?
|
| Communicable Diseases | 1 | 2021 | 83 | 0.180 |
Why?
|
| DNA, Viral | 2 | 2020 | 228 | 0.170 |
Why?
|
| Cisterna Magna | 1 | 2019 | 14 | 0.170 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 41 | 0.160 |
Why?
|
| Antigen Presentation | 1 | 2021 | 228 | 0.160 |
Why?
|
| Bone Resorption | 1 | 2019 | 49 | 0.160 |
Why?
|
| Ovalbumin | 1 | 2019 | 113 | 0.160 |
Why?
|
| Immunotherapy | 1 | 2021 | 235 | 0.160 |
Why?
|
| Macular Degeneration | 1 | 2021 | 179 | 0.150 |
Why?
|
| Genes, Recessive | 1 | 2018 | 52 | 0.150 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 176 | 0.150 |
Why?
|
| Neoplasms | 2 | 2021 | 1258 | 0.150 |
Why?
|
| Immunity, Innate | 2 | 2021 | 768 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2019 | 156 | 0.150 |
Why?
|
| Heterozygote | 1 | 2018 | 166 | 0.150 |
Why?
|
| Osteoporosis | 1 | 2019 | 139 | 0.150 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 23 | 0.150 |
Why?
|
| Gene Ontology | 1 | 2017 | 37 | 0.150 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 708 | 0.140 |
Why?
|
| Inverted Repeat Sequences | 1 | 2017 | 14 | 0.140 |
Why?
|
| Introns | 1 | 2017 | 106 | 0.140 |
Why?
|
| Computational Biology | 1 | 2019 | 329 | 0.140 |
Why?
|
| Alleles | 1 | 2018 | 422 | 0.140 |
Why?
|
| Transfection | 2 | 2017 | 675 | 0.140 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 90 | 0.140 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2016 | 5 | 0.130 |
Why?
|
| Embryonic Development | 1 | 2018 | 136 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2014 | 2100 | 0.130 |
Why?
|
| Alphavirus | 1 | 2015 | 3 | 0.130 |
Why?
|
| Colforsin | 1 | 2015 | 24 | 0.130 |
Why?
|
| Cell Lineage | 1 | 2017 | 249 | 0.130 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 77 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2014 | 1459 | 0.120 |
Why?
|
| Cyclic AMP | 1 | 2015 | 143 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 229 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 677 | 0.120 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 111 | 0.110 |
Why?
|
| Luciferases | 1 | 2014 | 109 | 0.110 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 330 | 0.110 |
Why?
|
| Risk Factors | 1 | 2023 | 5037 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2014 | 195 | 0.110 |
Why?
|
| Metalloproteases | 1 | 2013 | 4 | 0.110 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2013 | 12 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1134 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 525 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 35 | 0.100 |
Why?
|
| Frozen Sections | 1 | 2012 | 10 | 0.100 |
Why?
|
| Base Sequence | 1 | 2014 | 1311 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 145 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2012 | 125 | 0.090 |
Why?
|
| Monocytes | 1 | 2013 | 344 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1976 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 630 | 0.090 |
Why?
|
| Mutation | 1 | 2018 | 2461 | 0.090 |
Why?
|
| Serogroup | 2 | 2020 | 31 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 2 | 2021 | 176 | 0.080 |
Why?
|
| Chromatin | 1 | 2014 | 597 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2016 | 2890 | 0.080 |
Why?
|
| Virus Assembly | 2 | 2020 | 53 | 0.080 |
Why?
|
| Nucleic Acid Conformation | 2 | 2019 | 231 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 857 | 0.070 |
Why?
|
| Myocardium | 1 | 2007 | 263 | 0.060 |
Why?
|
| Binding Sites | 2 | 2021 | 870 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 2079 | 0.060 |
Why?
|
| Male | 6 | 2021 | 27765 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 856 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2024 | 206 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2017 | 385 | 0.050 |
Why?
|
| Mice, Inbred mdx | 1 | 2021 | 18 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 1378 | 0.050 |
Why?
|
| Dystrophin | 1 | 2021 | 35 | 0.050 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 26 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2022 | 95 | 0.050 |
Why?
|
| Intravitreal Injections | 1 | 2021 | 49 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2021 | 78 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 349 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 94 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2019 | 43 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 200 | 0.040 |
Why?
|
| Vaccines | 1 | 2021 | 97 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 56 | 0.040 |
Why?
|
| Catheters | 1 | 2019 | 67 | 0.040 |
Why?
|
| Sheep | 1 | 2019 | 168 | 0.040 |
Why?
|
| Cartilage | 1 | 2019 | 36 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 1527 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 334 | 0.040 |
Why?
|
| RNA Stability | 1 | 2019 | 94 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 126 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2019 | 111 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 221 | 0.040 |
Why?
|
| Female | 4 | 2021 | 31093 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 185 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2019 | 165 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 169 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 265 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 171 | 0.040 |
Why?
|
| Fallopian Tubes | 1 | 2018 | 12 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2019 | 298 | 0.040 |
Why?
|
| DNA End-Joining Repair | 1 | 2018 | 24 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 256 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 257 | 0.040 |
Why?
|
| Endonucleases | 1 | 2018 | 81 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 880 | 0.040 |
Why?
|
| Blastocyst | 1 | 2018 | 76 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2017 | 114 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 739 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2016 | 26 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 354 | 0.030 |
Why?
|
| Response Elements | 1 | 2016 | 42 | 0.030 |
Why?
|
| RNA Interference | 1 | 2019 | 593 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2019 | 508 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2016 | 78 | 0.030 |
Why?
|
| Oncolytic Virotherapy | 1 | 2015 | 6 | 0.030 |
Why?
|
| Oncolytic Viruses | 1 | 2015 | 7 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 498 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2015 | 49 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 397 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 38 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 255 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2015 | 60 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 909 | 0.030 |
Why?
|
| DNA Replication | 1 | 2017 | 229 | 0.030 |
Why?
|
| Synteny | 1 | 2014 | 24 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 647 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1996 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 463 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 483 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 17 | 0.030 |
Why?
|
| ADAM17 Protein | 1 | 2013 | 9 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 2013 | 30 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 38 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 139 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1470 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 323 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 751 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1141 | 0.020 |
Why?
|
| COS Cells | 1 | 2012 | 174 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 96 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2049 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 2359 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1040 | 0.020 |
Why?
|
| Proteomics | 1 | 2012 | 261 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1559 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 1918 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2007 | 41 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 218 | 0.020 |
Why?
|